文献库搜索 | GeneLibs

Margoni(A),Papavassiliou(KA),Papavassiliou... Oral Oncol 2026-04-00

...PIK3CA), tumor necrosis factor (TNF) receptor-associated factor 3 (TRAF3), and targetable receptor tyrosine kinase (RTK)...

Sambath(J),Achyutha(S),George(IA),Prabhash... Oral Maxillofac Surg Clin N... 2026-08-00

...PIK3CA, and AAM pathway genes), characteristic copy number alterations, and transcriptomic programs driven by extracellu...

Liu(L),Graff(SL),Hacking(S),Cheng(L),Wang(... Histopathology 2026-06-00

...PIK3CA and TP53 mutations and treatment-emergent ESR1 mutations, observed in both tissue and ctDNA. CDKN2A, SPEN, KIT, C...

Julka(PK),Arya(D),Gupta(S) Cureus 2026-01-00

...PIK3CA mutations) and pervasive tumor suppressor loss, with no microsatellite instability (MSI)-high cases. Gynecologic ...

Ooi(PJ),Ang(XJ),Ang(ACP),Chong(JY),Wong(JH... In Silico Pharmacol None

...PIK3CA, PIK3CD, HSP90AA1, and AKT1. These targets are involved in three immune-related signalling pathways, including T-...

Che(J),Kwon(WS),Kim(J),Jadamba(E),Han(HJ),... Sci Rep 2026-02-10

...PIK3CA, and CNVs, e.g., ERBB2 amplification in gastric (n = 412) and colorectal (n = 66) cancers. MSI and TMB were stron...

Varty(K),MacLean(L),Itani(D),Hossain(M),Ac... Genes Chromosomes Cancer 2026-02-00

...PIK3CA, with potential effects on MAPK/ERK and PI3K/AKT signaling. This cohort demonstrates both expected and distinct g...

Feng(C),Yang(C),Gao(W),Liu(Y),Wei(J),Shen(... Naunyn Schmiedebergs Arch P... 2026-05-00

...PIK3CA and p-PI3K and p-AKT. The results of cellular metabolomics analysis indicate that the drug-containing serum can r...

Xie(H),Wang(Y),Zhu(M),Hou(L),Sun(X),Gao(X)... Biol Proced Online 2026-07-18

...PIK3CA, and STAT3 as core targets key to RGHY compounds. RGHY was shown to significantly alleviate TAA-induced liver inj...

Liu(S),Sun(M),Wang(X),Feng(W) BMC Cancer 2026-07-18

...PIK3CA mutations, and good outcomes. C3 tumors were enriched for epithelial-mesenchymal transition and hypoxia programs,...